Skip to Content

Transparency.

It is essential that patients have confidence that the relationship between physicians (and other healthcare professionals) and the industry that commercializes medicines are open and transparent. We are fully committed to transparency to help increase patients' trust so the relation between health care professionals (HCPs), other relevant decision makers (ORDMs) and the pharmaceutical industry are open and transparent.

Almirall Ltd is fully committed and supports the ABPI (Association of British Pharmaceutical Industry) Disclosure and EFPIA Transparency Code to disclose direct or indirect transfers of value in cash or kind.

  • United Kingdom
    • 2018 (Information reported in external website)
    • 2017 (Information reported in external website)
    • 2016 (Information reported in external website)
  • Ireland
    • 2018 (Information reported in external website)
    • 2017 (Information reported in external website)
    • 2016 (Information reported in external website)